Search Results

You are looking at 1 - 2 of 2 items for

  • Author: L Fugazzola x
  • Refine by access: All content x
Clear All Modify Search
S Rossi
Search for other papers by S Rossi in
Google Scholar
PubMed
Close
,
L Fugazzola
Search for other papers by L Fugazzola in
Google Scholar
PubMed
Close
,
L De Pasquale
Search for other papers by L De Pasquale in
Google Scholar
PubMed
Close
,
P Braidotti
Search for other papers by P Braidotti in
Google Scholar
PubMed
Close
,
V Cirello
Search for other papers by V Cirello in
Google Scholar
PubMed
Close
,
P Beck-Peccoz
Search for other papers by P Beck-Peccoz in
Google Scholar
PubMed
Close
,
S Bosari
Search for other papers by S Bosari in
Google Scholar
PubMed
Close
, and
A Bastagli
Search for other papers by A Bastagli in
Google Scholar
PubMed
Close

We report the simultaneous occurrence of medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC), presenting as spatially distinct and well-defined tumour components, in three cases. In the first patient, histology, immunohistochemistry and electron microscopy demonstrated an MTC in the one nodule and PTC in two additional lesions. Non-neoplastic thyroid parenchyma separated the three nodules. Metastasis from PTC was diagnosed in a regional lymph node. Genetic analysis of both tumour components showed a distinctive mutational pattern: in the MTC a Cys634Arg substitution in exon 11 of the RET gene and in the two PTC foci a Val600Glu substitution in exon 15 of the BRAF gene. The other two patients are members of a large multigenerational family affected with familial MTC due to a germline mutation of the RET gene (Ala891Ser). Both patients harboured, besides medullary cancer and C-cell hyperplasia, distinct foci of papillary thyroid cancer, which was positive for Val600Glu BRAF mutation. Review of the literature disclosed 18 similar lesions reported and allowed the identification of different patterns of clinical presentation and biological behaviour. So far, the pathogenesis of these peculiar cases of thyroid malignancy has been completely unknown, but an underlying common genetic drive has been hypothesised. This is the first report in which two mutations, in the RET and BRAF genes, have been identified in three cases of MTC/PTC collision tumour, thus documenting the different genetic origin of these two coexisting carcinomas.

Free access
L Fugazzola
Search for other papers by L Fugazzola in
Google Scholar
PubMed
Close
,
E Puxeddu
Search for other papers by E Puxeddu in
Google Scholar
PubMed
Close
,
N Avenia
Search for other papers by N Avenia in
Google Scholar
PubMed
Close
,
C Romei
Search for other papers by C Romei in
Google Scholar
PubMed
Close
,
V Cirello
Search for other papers by V Cirello in
Google Scholar
PubMed
Close
,
A Cavaliere
Search for other papers by A Cavaliere in
Google Scholar
PubMed
Close
,
P Faviana
Search for other papers by P Faviana in
Google Scholar
PubMed
Close
,
D Mannavola
Search for other papers by D Mannavola in
Google Scholar
PubMed
Close
,
S Moretti
Search for other papers by S Moretti in
Google Scholar
PubMed
Close
,
S Rossi
Search for other papers by S Rossi in
Google Scholar
PubMed
Close
,
M Sculli
Search for other papers by M Sculli in
Google Scholar
PubMed
Close
,
V Bottici
Search for other papers by V Bottici in
Google Scholar
PubMed
Close
,
P Beck-Peccoz
Search for other papers by P Beck-Peccoz in
Google Scholar
PubMed
Close
,
F Pacini
Search for other papers by F Pacini in
Google Scholar
PubMed
Close
,
A Pinchera
Search for other papers by A Pinchera in
Google Scholar
PubMed
Close
,
F Santeusanio
Search for other papers by F Santeusanio in
Google Scholar
PubMed
Close
, and
R Elisei
Search for other papers by R Elisei in
Google Scholar
PubMed
Close

Recently, a somatic point mutation of the B-RAF gene (V600E) has been identified as the most common genetic event in papillary thyroid carcinoma (PTC), with a prevalence variable among different series. Since discordant data on the clinico-pathologic features of B-RAF mutated PTC are present in the literature, the aim of the present co-operative study was to establish the prevalence of this genetic alteration and to perform a genotype–phenotype correlation in a large cohort of patients with PTC. To this purpose, a series of 260 sporadic PTCs with different histological variants were included in the study. The mutational analysis of the B-RAF gene was performed either by RT-PCR followed by single-stranded conformational polymorphism or by PCR and direct sequencing. Statistical analyses were obtained by means of χ2/Fisher’s exact test and t-test. Overall, a heterozygous T > A transversion at nucleotide 1799 (V600E) was found in 99 out of 260 PTCs (38%). According to the histological type of the tumor, the B-RAF V600E mutation was present in 48.3% of cases of classic PTCs (85 out of 176), in 17.6% (nine out of 51) of follicular variants of PTCs, in 21.7% (five out of 23) in other PTC variants and in none of the ten poorly differentiated tumors. B-RAF V600E was significantly associated with the classic variant of PTC (P = 0.0001) and with an older age at diagnosis (P = 0.01). No statistically significant correlation was found among the presence of B-RAF V600E and gender, tumor node metastasis (TNM), multicentricity of the tumor, stage at diagnosis and outcome. In conclusion, the present study reports the prevalence of B-RAF V600E (38%) in the largest series of sporadic PTCs, including 260 cases from three different Italian referring centers. This prevalence is similar to that calculated by pooling together all data previously reported, 39.6% (759 out of 1914 cases), thus indicating that the prevalence of this genetic event lies around 38–40%. Furthermore, B-RAF V600E was confirmed to be associated with the papillary growth pattern, but not with poorer differentiated PTC variants. A significant association of B-RAF mutation was also found with an older age at diagnosis, the mutation being very rare in childhood and adolescent PTCs. Finally, no correlation was found with a poorer prognosis and a worse outcome after a median follow-up of 72 months.

Free access